• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From pituitary adenoma to PitNET: it is time to discuss PitNET/pituitary adenoma.

作者信息

Fushimi Yasutaka, Taoka Toshiaki, Naganawa Shinji

机构信息

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyoku, Kyoto, 6068507, Japan.

Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Shouwa-ku, Nagoya, 466-8550, Japan.

出版信息

Jpn J Radiol. 2023 Aug;41(8):787-788. doi: 10.1007/s11604-023-01412-3.

DOI:10.1007/s11604-023-01412-3
PMID:36933109
Abstract
摘要

相似文献

1
From pituitary adenoma to PitNET: it is time to discuss PitNET/pituitary adenoma.从垂体腺瘤到垂体神经内分泌肿瘤：是时候讨论垂体神经内分泌肿瘤/垂体腺瘤了。
Jpn J Radiol. 2023 Aug;41(8):787-788. doi: 10.1007/s11604-023-01412-3.
2
Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.揭示无细胞肿瘤的身份：表观基因组学证实了细微的组织学线索在垂体神经内分泌肿瘤/腺瘤分类中的作用。
Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12870. doi: 10.1111/nan.12870.
3
Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma.垂体瘤影像学：第 5 版 WHO 分类更新解读-第 1 部分。垂体神经内分泌肿瘤（PitNET）/垂体腺瘤。
Jpn J Radiol. 2023 Aug;41(8):789-806. doi: 10.1007/s11604-023-01400-7. Epub 2023 Feb 24.
4
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.从垂体腺瘤到垂体神经内分泌肿瘤（PitNET）：国际垂体病理俱乐部提议
Endocr Relat Cancer. 2017 Apr;24(4):C5-C8. doi: 10.1530/ERC-17-0004.
5
Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.2022 年世界卫生组织垂体腺瘤/垂体神经内分泌肿瘤分类概述：临床实践、争议和观点。
Curr Med Sci. 2022 Dec;42(6):1111-1118. doi: 10.1007/s11596-022-2673-6. Epub 2022 Dec 22.
6
SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth Targeting VEGFA.SDF-1α/miR-134 轴调控非功能性垂体神经内分泌肿瘤生长并靶向 VEGFA。
Front Endocrinol (Lausanne). 2020 Dec 9;11:566761. doi: 10.3389/fendo.2020.566761. eCollection 2020.
7
Evaluating the expression pattern of the opioid receptor in pituitary neuroendocrine tumors (PitNET) and the role of morphine and naloxone in the regulation of pituitary cell line growth and apoptosis.评估阿片受体在垂体神经内分泌肿瘤（PitNET）中的表达模式以及吗啡和纳洛酮在调节垂体细胞系生长和凋亡中的作用。
Biomed Pharmacother. 2023 Jan;157:114022. doi: 10.1016/j.biopha.2022.114022. Epub 2022 Nov 19.
8
The molecular biology of thyrotroph pituitary neuroendocrine tumors.促甲状腺激素垂体神经内分泌肿瘤的分子生物学。
Endocr J. 2023 Feb 28;70(2):135-139. doi: 10.1507/endocrj.EJ22-0514. Epub 2023 Jan 19.
9
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?从垂体腺瘤到垂体神经内分泌肿瘤：分子途径如何影响治疗管理？
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1744-1759. doi: 10.2174/1871530321666210226152901.
10
Pituitary adenoma…nomen omen?垂体腺瘤……名副其实？
Endocrine. 2021 Oct;74(1):1-4. doi: 10.1007/s12020-021-02785-z. Epub 2021 Jun 10.

引用本文的文献

1
Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine.肾上腺疾病多模态成像的进展：整合CT、MRI和核医学
Jpn J Radiol. 2025 Jan 11. doi: 10.1007/s11604-025-01732-6.
2
[Unification of pathomorphological examination of patients with neuroendocrine tumors of the pituitary gland. Controversial issues of the new classification].[垂体神经内分泌肿瘤患者病理形态学检查的统一。新分类的争议问题]
Probl Endokrinol (Mosk). 2023 Nov 14;70(3):31-45. doi: 10.14341/probl13376.

本文引用的文献

1
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
2
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?垂体肿瘤命名研讨会：腺瘤经得起时间的考验吗？
J Endocr Soc. 2021 Feb 9;5(3):bvaa205. doi: 10.1210/jendso/bvaa205. eCollection 2021 Mar 1.
3
A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement.垂体腺瘤的故事：是神经内分泌肿瘤还是非神经内分泌肿瘤：垂体学会立场声明
Pituitary. 2019 Dec;22(6):569-573. doi: 10.1007/s11102-019-00988-2.
4
The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.冰岛 1955-2012 年垂体腺瘤的流行病学：一项全国基于人群的研究。
Eur J Endocrinol. 2015 Nov;173(5):655-64. doi: 10.1530/EJE-15-0189.